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Edited by Gianni CesareniAbstract WD repeats are implicated in protein–protein inter-
actions and regulate a wide variety of cellular functions,
including chromatin remodeling and transcription. The WD
repeats of the Bub3 and Cdc20 kinetochore proteins are
important for the physical interactions of these proteins with
Mad2 and BubR1 to yield a kinetochore protein complex
capable of delaying anaphase by inhibiting ubiquitin ligation via
the anaphase-promoting complex/cyclosome. Here, we show that
Bub3 and Cdc20 form a complex with histone deacetylases; this
interaction appears to confer transcriptional repressor activity in
a heterologous DNA-binding context. In addition, inhibition of
Bub3 and Cdc20 expression signiﬁcantly impairs interphase cell
cycle. These results indicate that Bub3 and Cdc20 play
additional roles in the integration of cell cycle arrest as
transcriptional repressors.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The WD repeats are a conserved sequence motif usually
ending with Trp-Asp (WD), and WD repeat proteins are found
in all eukaryotes and have been implicated in a wide variety of
crucial functions, including gene expression, RNA processing,
signal transduction and cell division [1,2]. All WD repeat
proteins are thought to fold into propeller-shaped structures in
which the internal b-strands form a rigid skeleton that is ﬂe-
shed out on the surface by specialized loops responsible for
binding other proteins. A number of studies have revealed that
many WD repeat-containing proteins interact with histone
deacetylases (HDACs) and function as transcriptional repres-
sors to regulate the expression of genes involved in the cell
cycle and chromatin assembly [2,3]. For instance, chromatin
assembly factor-1 (CAF-1), which is essential for chromatin
assembly, interacts with HDAC2 through its WD repeat [2]. In
addition, overexpression of the WD repeat-containing TATA-
binding protein-associated factors, TAF72 or TAF73, sup-* Corresponding author. Fax: +82-31-920-1520.
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phase-promoting complex/cyclosome (APC/C)-mediated
ubiquitination [3].
The mitotic checkpoint ensures accurate chromosome seg-
regation by sensing unaligned chromosomes and delaying
anaphase until proper alignment is achieved; defects in this
checkpoint mechanism result in the chromosomal instability
implicated in tumorigenesis. Components of the mitotic
checkpoint machinery include Bub1, Bub3, BubR1 (a homolog
of yeast Mad3), Mad1, Mad2, Mad3, Mps1, and CENP-E (a
microtubule-dependent motor protein) [4–7]. When the spindle
checkpoint is activated at unattached kinetochores, the mitotic
checkpoint proteins (MCPs) BubR1, Bub3 and Mad2 bind to
and inhibit Cdc20, an activator of the APC/C, and then pro-
duce a diﬀusible ‘‘wait anaphase’’ signal that inhibits the APC
and delays the onset of anaphase [4–7]. Fractionation experi-
ments have suggested that BubR1, Bub3 and Mad2 may be
concomitantly present in a protein complex with Cdc20; for-
mation of the Bub3–Cdc20 complex is mediated via WD re-
peats [8]. Bub3 protein levels are constant throughout the cell
cycle, whereas Cdc20 protein accumulates during mitosis and
is degraded to almost undetectable levels prior to cytokinesis.
Although the levels of the Bub3–Cdc20 complex vary during
the cell cycle, these variations do not precisely reﬂect the pe-
riodicity of the Cdc20 protein levels. In addition, it has been
suggested that a pool of free Cdc20 exists separate from the
Bub3 complex even during checkpoint activation [9]. It is in-
teresting to note that Cdc20 associates with diﬀerent proteins
at diﬀerent subcellular locations during the cell cycle; a dra-
matic change occurs in the patterns of protein association
during the transitions from G2 to M and M to G1 [8–10].
Taken together, these observations suggest that the mitotic
checkpoint proteins may play additional, unexplored roles in
interphase cells. Of these, Bub3 and Cdc20 are good candi-
dates to mediate protein complex assembly during the cell
cycle, because these proteins contain WD repeats, which have
been strongly implicated in protein–protein interactions.
Here, we investigated the role of these MCPs in interphase
cells. Cell cycle analysis of siRNA-transfected cells revealed
that inhibition of endogenous Bub3 or Cdc20 signiﬁcantly
reduced the proportion of S and G2/M cells, respectively,
suggesting that Bub3 and Cdc20 may be involved in mediating
the G2 and G1 phases, respectively. Furthermore, we found
that WD repeat-containing Bub3 and Cdc20 are present in aation of European Biochemical Societies.
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scriptional repressors in the DNA-binding context. This is the
ﬁrst report of a role for Bub3 and Cdc20 in the integration of
cell cycle arrest during interphase.2. Materials and methods
2.1. Cell culture
HeLa cells were cultured in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (FBS, Hyclone)
and antibiotics. For cell cycle analysis, MRC-5 primary cells were
cultured in minimum essential medium (MEM) with 2 mM L-gluta-
mine and Earle’s BSS adjusted to contain 1.5 g/L sodium bicarbonate,
0.1 mM non-essential amino acids, 1.0 mM sodium pyruvate, 10% FBS
and antibiotics.
2.2. siRNA synthesis
The following gene-speciﬁc sequences were used to generate siRNAs
(Dharmacon): siBub3 50-AGCGACUGUGCCAAUUCCA-30; siMad2
50-GGAAGAGUCGGACCACAG-30; siCdc20 50-CGGCAGGA-
CUCCGGGCCGA-30 [11]; siCdh1 50-UGAGAAGUCUCCCAGU-
CAG-30 [11]; and siLuciferase (as a control) 50-CGT ACG CGG AAT
ACT TCG A-30 [12].
2.3. Plasmids and transfection
cDNAs of Bub1, Bub3, Mad1, Mad2, BubR1, Cdc20 and Cdh1 were
ampliﬁed by PCR using templates generated by reverse transcription
from HeLa cell total mRNA, with oligo-dT as a primer. PCR products
were then cloned into the pGEX-KG to generate GST-Bub1, -Bub3,
-Mad1, -Mad2, -BubR1, -Cdc20 and -Cdh1, respectively. The plasmids
expressing Gal4 DNA-binding domain and the MCP fusion proteins,
Bub1, Bub3, Mad1, Mad2, BubR1, Cdc20 or Cdh1, were constructed
by insertion of each MCP open reading frame into the pSG424 vector
[13]. To create the Gal4-fused Bub3 or Cdc20 deletion mutants, each
DNA fragments of Bub3 or Cdc20 as indicated in Fig. 4A and B were
ampliﬁed by PCR and subsequently inserted into the pSG424 vector.
Gal4-Rb was described previously [14].
MRC-5 primary cells were electroporated with siRNA. Brieﬂy,
subconﬂuent monolayers of MRC-5 primary cells were detached from
the culture dishes by trypsin treatment, washed with phosphate-
buﬀered saline, and adjusted to a concentration of 2 106 cells per ml
in complete medium. Then, 300 ll of the cell suspension (6 105 cells)
was mixed with 20 lg siRNA by gentle pipetting, transferred to a 0.4-
cm width electroporation cuvette (Bio-Rad), and subjected to an
electric pulse at 900 lF and 220 V using a Gene Pulser (Bio-Rad). Cells
were immediately transferred to 8 ml of complete media and 4 ml
samples were seeded into 6-cm-diameter cell culture dishes.
2.4. Flow cytometry and immunoblotting
MRC-5 cells were harvested 24 and 48 h after siRNA electropora-
tion for ﬂow cytometry and immunoblotting. Cells were resuspended
in 400 ll of cold PBS, ﬁxed by dropwise addition of 360 ll cold 100%
ethanol with gentle vortexing, and then placed at )20 C. Fixed cells
were washed in PBS, stained with propidium iodide (40 lg/ml) and
treated with RNase A (50 lg/ml) for 30 min at room temperature.
Samples of 10 000 cells were analyzed for DNA content. Data were
generated with the CellQuest software (Becton–Dickinson).
Immunoblotting was performed to conﬁrm the siRNA knock-down
eﬀect. Whole cell lysates of MRC-5 cells were prepared in lysis buﬀer
(20 mM HEPES, pH 7.6, 250 mM NaCl, 1.5 mM MgCl2, 2 mM
EDTA, 20% Glycerol, 0.1% Nonidet P-40, 1 mM dithiothreitol (DTT),
protease inhibitor cocktail (PIC, Roche) and 200 lM PMSF). Equal
amounts of protein quantitated by Bradford assay (Bio-Rad) were
separated by SDS–PAGE and transferred to a nitrocellulose mem-
brane. For immunoblot analysis, blots were incubated with anti-Cdh1,
anti-Cdc20 or anti-Bub3 antibodies, with anti-Actin antibody used as
an internal control.2.5. Pull-down assay and immunoprecipitation
GST-Bub1, -Bub3, -Mad1, -Mad2, -BubR1, -Cdc20 and -Cdh1 en-
code a complete Bub1, Bub3, Mad1, Mad2, BubR1, Cdc20 and Cdh1
proteins, respectively, fused toGST in pGEX-KGandwere induced andpuriﬁed by conventional procedures. Fusion proteins bound to gluta-
thione–agarose beads were incubated with 600 lg/ml extracts prepared
from untreated and nocodazole treated HeLa cells for 4 h at 4 C.
For immunoprecipitation, cell pellets from HeLa cells were ﬁrst lysed
in buﬀer A (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5
mM dithiothreitol (DTT), protease inhibitor cocktail (PIC, Roche) and
200 lMPMSF) for 5 min on ice and centrifuged at 2000 rpm for 3 min.
Then, the pellets were lysed in IPH buﬀer (50 mMTris, pH 8.0, 150 mM
NaCl, 0.5% NP-40, 5 mM EDTA and protease inhibitor cocktail
(Roche)). The protein concentration of the lysates was determined by
Bradford assay (Bio-Rad). Lysates were incubated for 2 h at 4 C with
Protein-G or -A–agarose (Amersham) with immunoglobulin (IgG,
Santa Cruz), to clear the lysates. The cleared lysates were then incu-
bated overnight at 4 C with anti-HDAC1 (Santa Cruz), anti-HDAC2
(Santa Cruz), anti-Cdc20 (Santa Cruz), anti-Cdh1 (Oncogene), anti-
Bub3 (Pharmingen), anti-Mad2 (Pharmingen) or anti-pRb (Santa
Cruz). The beads were then incubated for 2 h at 4 C, and the bound
proteins were eluted with 2 SDS loading buﬀer and analyzed by im-
munoblotting with the appropriate antibody.
2.6. Gene reporter assays
For luciferase assay, cell extracts were prepared in reporter lysis
buﬀer (Promega). After removing cell debris, extracts were assayed for
luciferase activity by mixing 300 ll luciferase reagent (Promega) with
60 ll cell extracts and measuring the activity with luminometer. b-
Galactosidase assays were performed as described previously [15].3. Results and discussion
3.1. WD repeat-containing Bub3 and Cdc20 are potentially
involved in the regulation of cell cycle arrest during
interphase
It has been well documented that mitotic checkpoint pro-
teins such as Bub1, Bub3, Mad1, Mad2, BubR1 (Mad3/Bub1-
related kinase) and Cdc20 are localized at kinetochores. In
addition, these proteins are essential for cellular progression
through mitosis, as they are necessary for APC/C-mediated
activation of the mitotic checkpoint [16–18]. However, these
MCPs are found in a multiprotein complex even in interphase
cells, suggesting that the MCP complex might additionally
function at other points during the cell cycle. Interestingly,
WD repeats are important in the formation of the Bub3–
Mad2–Mad3–Cdc20 complex and have been strongly impli-
cated in protein–protein interactions (Fig. 1A) [8]. In an eﬀort
to begin investigating the role of mitotic checkpoint proteins
during interphase, we transfected various siRNAs designed to
cause posttranscriptional gene silencing of Mad2, Bub3,
BubR1, Cdc20 and Cdh1. The speciﬁcity of these siRNAs was
conﬁrmed by our observation that endogenous Mad2, Bub3,
BubR1, Cdc20 and Cdh1 protein levels were reduced in siR-
NA-transfected cells, whereas the control luciferase siRNA
had no eﬀect on these protein levels (Fig. 1B). To examine the
eﬀect of siRNA-induced Mad2, Bub3, BubR1, Cdc20 and
Cdh1 knock-down on cell cycle progression, MRC-5 cells
transfected with each siRNA were harvested for ﬂow cytom-
etry analysis, and analyzed for the proportion of transfected
cells in the G1, S and G2/M phases (Figs. 1C and D). Cells
transfected with the Mad2 or BubR1 siRNA showed little
diﬀerence from control cells transfected with luciferase siRNA
in terms of cell cycle proﬁle. Cells transfected with Cdh1
showed slightly increased proportions of cells in S phase, an
observation that is consistent with a previous report demon-
strating that Cdh1 was required for G1 cell cycle arrest [17,19].
In contrast, cells transfected with Bub3 or Cdc20 siRNA
showed signiﬁcant increases in the G1 and G2/M or S phase
Fig. 1. Inhibition of Bub3 and Cdc20 expression signiﬁcantly aﬀects cell cycle arrest in G2 and G1 phases, respectively. (A) Schematic summary of
MCP domains: The functional domains found in the various MCPs include the Bub, Mad or Cdc20-interaction domain, the kinase domain, the N-
terminal homology domain, and the WD repeat region. (B) MRC-5 cells were transiently transfected with one of the following: control luciferase
siRNA, Mad2 siRNA, Bub3 siRNA, Cdc20 siRNA or Cdh1 siRNA. Transfected cells were harvested and analyzed by immunoblotting with anti-
Mad2, anti-Bub3, anti-Cdc20, anti-Cdh1 or anti-Actin antibodies. (C and D) Quantitative comparison of cell cycle arrest in MRC-5 cells treated with
siRNA as described in Section 2. siRNA-transfected cells were harvested, stained with propidium iodide and analyzed by ﬂow cytometry. Relative
proportions of G1, S and G2/M phase cells by the diﬀerent siRNA treatments were derived from the ﬂow cytometry. M1, M2 and M3 indicate G1, S
and G2/M populations of cells, respectively.
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S or G2/M phase populations. Together, these results suggest
that the WD repeat-containing proteins Bub3 and Cdc20 play
roles in cell cycle arrest during interphase.
3.2. MCP/Gal4 DNA-binding domain fusion proteins show
transcriptional repression activity
Recent studies have demonstrated that some WD repeat
proteins function as transcriptional repressors to regulategenes involved in the cell cycle and chromatin assembly [1–
3]. To test the role of WD repeat-containing MCPs in
transcriptional repression, we fused these proteins with the
Gal4 DNA-binding domain (Gal4) to generate Gal4-Bub1,
Gal4-Bub3, Gal4-Mad1, Gal4-Mad2, Gal4-BubR1, Gal4-
Cdc20 and Gal4-Rb fusion proteins (Fig. 2A). Expression of
the chimeric proteins in transfected cells was veriﬁed by
immunoblotting analysis using an anti-Gal4 antibody (data
not shown). HepG2 (lanes 1–6), HeLa S3 (lanes 7–12) and
Fig. 2. Transcriptional repression activity of mitotic checkpoint proteins artiﬁcially recruited to DNA by means of the Gal4 DNA-binding domain.
(A) Schematic of Gal4 (G4)-fused MCPs. (B) The Gal4 reporter, G5E1b-luciferase (1 lg), was co-transfected into HepG2 (lanes 1–6), HeLaS3 (lanes
7–12) or HeLa (lanes 13–17) cells together with G4 expression vectors (5 lg) encoding the Gal4 DNA-binding domain or the MCP fusion proteins
Bub1, Bub3, Mad1, Mad2, BubR1 or Cdc20, or Rb (as a control). pCMV-bgal (1 lg) was included in each transfection as an internal control. Cells
were assayed for luciferase and b-galactosidase activity 40 h post-transfection. The relative activity of luciferase to b-galactosidase is presented. The
results represent the averages of at least three independent experiments.
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reporter plasmid controlled by ﬁve copies of the Gal4-
binding site and the HSV tk promoter (pG5E1b-luc),
together with Gal4-Bub1, Gal4-Bub3, Gal4-Mad1, Gal4-
Mad2, Gal4-BubR1, Gal4-Cdc20 or Gal4-Rb (as a control).
Gal4-Bub3 and Gal4-Cdc20 eﬃciently repressed transcrip-
tional activity in all three tested cell lines (Fig. 2B). Unex-
pectedly, expression of Gal4-BubR1 and Gal4-Mad1 (to a
lesser degree) also led to signiﬁcant reduction of reporter
gene activity (Fig. 2B). Furthermore, MCPs including
BubR1 and Mad1 did not repress transcription in the ab-
sence of a heterologous DNA-binding context (data not
shown), and thereby circumvent potential artifacts arising
from non-speciﬁcity for the repression. In addition, we ob-
tained similar results when these experiments were repeated
in diﬀerent DNA-binding contexts, such as the use of the
E2F-1 DNA-binding domain instead of the Gal4 DNA-
binding domain (data not shown). Taken together, these
data suggest that MCPs, but not all of them, might be in-
volved in transcriptional repression.
3.3. Bub3 and Cdc20 may interact directly with HDAC1 and
HDAC2
The above results demonstrated that some MCPs may act as
transcriptional repressors in a heterologous DNA-binding
context. To examine this further, we next tested whether there
is a direct interaction between HDACs and MCPs by in vitroco-immunoprecipitation and pull-down assays. Escherichia
coli-expressed GST-Bub1, -Bub3, -Mad1, -Mad2, -BubR1,
-Cdc20 and -Cdh1 fusion proteins were puriﬁed and incubated
with lysates from HeLa cells cultured in the absence or pres-
ence of nocodazole (Fig. 3A). GST-Bub3, -BubR1, -Cdc20 and
-Cdh1 exhibited a clear binding activity toward the HDAC1
protein, as tested by immunoblotting with an anti-HDAC1
antibody. GST-Bub1 and -Mad1 showed very weak interac-
tions with HDAC1, whereas GST and GST-Mad2 showed no
binding under the same conditions. These interactions were
not inﬂuenced by nocodazole treatment. Anti-HDAC2 im-
munoblotting showed that HDAC2 interacted with GST-
Bub3, -Mad1, -Cdc20 and -Cdh1 but not with GST-Bub1,
-Mad2 or -BubR1 (Fig. 3A). Interestingly, these results ap-
peared to parallel the transcriptional repression activity of
these constructs, as presented in Fig. 2B. To further verify the
data of our pull-down assays, we performed a co-immuno-
precipitation experiment. Unlikely our pull-down results,
HDAC1 and HDAC2 appeared to only interact with Bub3,
whereas under the same experiment conditions, we could not
detect binding of Mad2, BubR1 or Mad1 to HDAC1 or
HDAC2, even when positive control immunoprecipitations
showed clear recognition of Mad2, BubR1 and Mad1 proteins
by the employed antibodies (Fig. 3B). Our failure to detect
HDAC complexes containing BubR1 or Mad1 in the co-im-
munoprecipitations may indicate that these protein complexes
could be formed by weak indirect protein–protein interactions,
Fig. 3. WD repeat-containing Bub3 and Cdc20 are present in a complex with HDAC1 and HDAC2. (A) In vitro binding assay between HDAC1 or
HDAC2 and GST fusion proteins encoding Bub1, Bub3, Mad1, Mad2, BubR1, Cdc20 and Cdh1. The indicated GST fusion proteins were incubated
with extracts prepared from untreated ()) and nocodazole (Noco)-treated (+) HeLa cells. After incubation, immunoblotting was performed with
either anti-HDAC1 (upper) or anti-HDAC2 (lower) antibodies. Lanes 1, 2 and 15 show the input extract (5%). (B) Co-immunoprecipitation of
endogenous HDACs and mitotic checkpoint proteins from HeLa cell extracts was performed using anti-IgG (negative control), anti-HDAC1 or anti-
HDAC2 followed by immunoblotting with anti-Bub3, anti-Mad2, anti-BubR1 or anti-Mad1 antibodies (left panels). As a control, immunopre-
cipitation was further performed with anti-IgG, anti-Mad2, anti-BubR1 or anti-Mad1 followed by immunoblotting with anti-Mad2 (lanes 5–7),
anti-BubR1 (lanes 8–10) or anti-Mad1 (lanes 11–13) as indicated (right panels). (C) Co-immunoprecipitation of endogenous HDACs and Cdc20
from HeLa cell extracts was performed using anti-IgG (negative control), anti-HDAC1, anti-HDAC2 (lanes 1–4, upper and lanes 5–7) or anti-Cdc20
(lanes 8–10) followed by immunoblotting with antibodies as indicated. To normalize these immunoprecipitation conditions, cell extracts were taken
at the same time as used above, and anti-Cdc20 (positive control) or anti-Cdh1 (negative control) immunoprecipitations were conﬁrmed by im-
munoblotting with anti-Cdc20, anti-BubR1 and anti-Bub3 antibodies, respectively (lanes 11–14).
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other HDAC family members. However, these points remain
to be further addressed. Next, immunoprecipitation with
anti-HDAC1 or anti-HDAC2 antibodies followed by immu-
noblotting with anti-Cdc20 antibody revealed that Cdc20 sig-
niﬁcantly interacted with HDAC1 and HDAC2 (Fig. 3C, lanes
1–7). We observed the similar result when the immunopre-
cipitation was performed with anti-Cdc20 and subsequent
immunoblotting with anti-HDAC1 or anti-HDAC2 antibody,
conﬁrming that Cdc20 makes a complex with HDAC protiens
(Fig. 3C, lanes 8–10). In a positive control experiment, we
conﬁrmed that under these experimental conditions, Cdc20Fig. 4. The WD repeats of Bub3 and Cdc20 are responsible for transcriptiona
and Cdc20 (B), with the WD repeats indicated as a shaded box. Gal4-fused Bu
Gal4 reporterG5E1b-luciferase (1 lg) intoHeLa cells. pCMV-bgal (1 lg) was i
luciferase and b-galactosidase activity 40 h post-transfection. The results show
Histone deacetylases participate in transcriptional repression of Bub3 and Cdc
intoHeLa cells withG4-Bub3D1,G4-Bub3WT,G4-RborG4-Cdc20. Sixteen h
(+) of the histone deacetylase inhibitor, trichostatin A (TSA), for a further 24can complex with its well-deﬁned interacting proteins, BubR1
and Bub3. The negative control conﬁrmed that Cdh1 was not
co-immunoprecipitated with these proteins. Thus, our data
indicate that Bub3 and Cdc20 interact with HDACs and ap-
pear to be involved in the regulation of transcriptional re-
pression. One interesting question remaining to be addressed is
whether the interactions of Bub3 and Cdc20 with HDACs are
dependent on the damage checkpoint for induction of G1 and/
or G2 arrest. However, the observation that the Bub3–HDAC
and Cdc20–HDAC complexes are constitutively present dur-
ing interphase seems to suggest that these complexes are in-
volved in normal cell cycle control throughout G1 and G2.l repression activity. (A and B) Schematic representations of Bub3 (A)
b3 or Cdc20 deletion mutants (5 lg) were transfected together with the
ncluded in each transfection as an internal control. Cells were assayed for
n represent the averages from at least three independent experiments. (C)
20 proteins. The Gal4 reporter G5E1b-luciferase (1 lg) was transfected
ours post-transfection, cells were incubated in the absence ()) or presence
h. The relative activity of luciferase to b-galactosidase is presented.
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their transcriptional repression activity
WD repeats have been widely implicated in substrate-spe-
ciﬁc protein–protein interactions. Bub3 and Cdc20 contain
three and seven WD repeats, respectively, based on their
amino acid sequence similarities to the known WD repeat
proteins. To examine the dependence of the observed tran-
scriptional repression activity on these repeats, we constructed
a series of Bub3 (Fig. 4A) and Cdc20 (Fig. 4B) WD repeat
deletion mutants and studied their transcriptional repression
activities using a luciferase reporter assay. Interestingly, Bub3
D2, D3, D4 and D5 mutants, which all contain repeats number
WD2 and/or WD3, eﬃciently repressed the transcriptional
activity to a similar degree as Bub3 WT (wild type), whereas
Bub3 D1, which possessed only WD1, showed in the complete
abrogation of repression activity (Fig. 4A). These results in-
dicated that repeats WD2 and WD3 are involved in the tran-
scriptional repression activity of the Bub3 protein. Using the
same approach, we investigated the WD region in Cdc20 and
its eﬀects on transcriptional repression. Interestingly, the
complete deletion of Cdc20 WD repeats D1–7 showed the al-
most loss of repression activity. However, although Cdc20
deletion mutants D1–3, D4–5 and D6–7 showed the repression
activity, the activity was noticeably lower than that of Cdc20
WT, suggesting that a broad region of Cdc20 WD repeats is
involved in transcriptional repression.
Next, we examined whether the transcriptional repression of
WD repeat-containing Bub3 and Cdc20 is mediated by their
interaction with HDAC, by assessing the ability of a histone
deacetylase inhibitor, trichostatin A (TSA), to inhibit the ob-
served transcriptional repression. HeLa cells were transfected
with G4-Bub3 D1, G4-Bub3 WT or G4-Rb (as a control) and
cultured in the absence or presence of TSA (Fig. 4C, lanes 1–
6). The transcriptional repression activity of G4-Bub3 WT and
G4-Rb was signiﬁcantly abrogated by TSA treatment. In
contrast, the activity of transcriptional repression-incompetent
G4-Bub3 D1 was not inﬂuenced by TSA. Similarly, in the
presence of TSA, the repression of G4-Cdc20 was almost
completely abolished (Fig. 4C, lanes 7–9). Together, these re-
sults indicate that Bub3 and Cdc20 require histone deacetylase
activity for their involvement in the process of transcriptional
repression during interphase.
A series of studies have reported that the direct stochio-
metric binding of sets of MCPs containing BubR1, Bub3,
Mad2, Cdc20 or subsets of these proteins is responsible for the
inhibition of APC/C-Cdc20 [16–18]. These proteins are disso-
ciated from intact kinetochores when cells exit from mitotic
arrest; during interphase, they may be abundantly present as
high levels of the complex, as basal levels of the complex, or in
pools of free MCPs. Recent studies have suggested that Cdc20
(and possibly other MCPs) associates with diﬀerent proteins at
diﬀerent subcellular locations during the cell cycle [8,9,20,21].
Recent important data by Sanchez and colleagues suggested
that Cdc20 is phosphorylated on PKA consensus sites after
DNA damage, and the phosphorylation regulates Cdc20 in-
teraction with its substrates such as Clb2. In addition, they
reported that the levels of Cdc20 were high in mitosis and
declined rapidly as the cells completed mitosis. However, in
cells with a DNA damage signal, Cdc20 levels remained high
throughout the pre-anaphase arrest [21]. These observationsstrongly raise the possibility that MCPs may be also involved
in the harmonized interphase cell cycle. Interestingly, we have
recently veriﬁed that BubR1 induces apoptotic death of cells
arrested at G1 and G2 after exposure to DNA damaging
agents and irradiation, respectively, indicating that BubR1 is
not only a sensor for monitoring the mitotic checkpoint, but it
also plays an additional role during interphase [22]. Moreover,
it has been well documented that another WD repeat protein,
Cdh1, activates APC/C to target mitotic cyclins from the end
of mitosis to the G1 phase. Recently, Saya and colleagues [19]
reported that Cdh1 plays multiple roles during interphase,
including mediation of Cdk inhibitor-dependent G1 arrest and
DNA damage-induced G2 arrest.
Although it is not yet clear whether the WD repeat-
containing mitotic checkpoint proteins Bub3 and Cdc20
directly bind DNA for regulation of transcriptional repression,
this study shows for the ﬁrst time that Bub3 and Cdc20 play
important roles in the control of interphase cell cycle, and this
function appears to be mediated by their interaction with
HDAC.
Acknowledgements: We thank Dr. Frank McKeon for providing ma-
terials. This work was supported by research grant from National
Cancer Center (0210100-3).References
[1] Smith, T.F., Gaitatzes, C., Saxena, K. and Neer, E.J. (1999)
Trends Biochem. Sci. 24, 181–185.
[2] Ahmad, A., Takami, Y. and Nakayama, T. (1999) J. Biol. Chem.
274, 16646–16653.
[3] Mitsuzawa, H., Seino, H., Yamao, F. and Ishihama, A. (2001) J.
Biol. Chem. 276, 17117–17124.
[4] Taylor, S.S. and McKeon, F. (1997) Cell 89, 727–735.
[5] Waters, J.C., Chen, R.-H., Murray, A.W. and Salmon, E.D.
(1998) J. Cell Biol. 141, 1181–1191.
[6] Chan, G.K.T., Jablonski, S.A., Sudakin, V., Hittle, J.C. and Yen,
T.J. (1999) J. Cell Biol. 146, 941–954.
[7] Abrieu, A., Kahana, J.A., Wood, K.W. and Cleveland, D.W.
(2000) Cell 102, 817–826.
[8] Fraschini, R., Beretta, A., Sironi, L., Musacchio, A., Lucchini, G.
and Piatti, S. (2001) EMBO J 20, 6648–6659.
[9] Harper, J.W., Burton, J.L. and Solomon, M.J. (2002) Genes Dev.
16, 2179–2206.
[10] Weinstein, J. (1997) J. Biol. Chem. 272, 28501–28511.
[11] Brummelkamp, T.R., Bernards, R. and Agami, R. (2002) Science
296, 550–553.
[12] Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber,
K. and Tuschl, T. (2001) Nature 411, 494–498.
[13] Lee, C.W., Sorensen, T.S., Shikama, N. and La Thangue, N.B.
(1998) Oncogene 16, 2695–2710.
[14] Luo, R.X., Postigo, A.A. and Dean, D.C. (1998) Cell 92, 463–473.
[15] Jooss, K., Lam, E.W., Bybee, A., Girling, R., Muller, R. and La
Thangue, N.B. (1995) Oncogene 10, 1529–1536.
[16] Musacchio, A. and Hardwick, K.G. (2002) Nat. Rev. Mol. Cell
Biol. 3, 731–741.
[17] Peters, J.M. (2002) Mol. Cell 9, 931–943.
[18] Yu, H. (2002) Curr. Opin. Cell Biol. 14, 706–714.
[19] Sudo, T., Ota, Y., Kotani, S., Nakao, M., Takami, Y., Takeda, S.
and Saya, H. (2001) EMBO J. 20, 6499–6508.
[20] Camasses, A., Bogdanova, A., Shevchenko, A. and Zachariae, W.
(2003) Mol. Cell 12, 87–100.
[21] Searle, J.S., Schollaert, K.L., Wilkins, B.J. and Sanchez, Y. (2004)
Nat. Cell Biol. 6, 138–145.
[22] Shin, H.J., Baek, K.H., Jeon, A.H., Park, M.T., Lee, S.J., Kang,
C.M., Lee, H.S., Yoo, S.H., Chung, D.H., Sung, Y.C., McKeon,
F. and Lee, C.W. (2003) Cancer Cell 4, 483–497.
